Skip to main content

Eatris in the Czech Republic

EATRIS in the Czech Republic

Czech Republic joined EATRIS consortium in 2011 during transitional phase. EATRIS entered to ERIC (EATRIS-ERIC) in 2014 and the Czech Republic became one of the founding countries.

Czech institutions are involved in the activities of platforms Small Molecules, Biomarkers, Vaccines, and Imaging and Tracing. The mission of the Czech EATRIS network (EATRIS-CZ) is to further develop a dynamic and collaborative environment that will support chemical, biomedical, and clinical research, and speed up its transfer into clinical practice. It will connect and facilitate collaboration of top national research institutions and hospitals in the research partnership. EATRIS-CZ will lead to the development of new knowledge and it will place the Czech Republic among nationally and internationally recognized centres of excellence in molecular and translational medicine directly linked to EATRIS and other major biomedical infrastructures.

Product platforms
EATRIS-CZ product platforms
more info
Available services
Detail of all available services
more info


Translational medicine is the transformation of laboratory research outcomes into new ways to diagnose and treat patients to improve the health of millions of people worldwide. It takes promising biomedical innovations 'from bench to bedside' and bridges clinical needs from bedside to bench.

EATRIS provides a new development pathway, open to researchers and companies in need of support for advancing biomedical innovations. EATRIS comprises over 80 leading academic institutions across Europe, each renowned for its individual and high-end research facilities.


  • Single point of access to the right expertise and facilities
  • Expedites the development process
  • Access to large and diverse clinical patient cohorts
EATRIS pipeline


Development and operation of EATRIS-ERIC-CZ, a national reflection of  EATRIS-ERIC, is funded by the Ministry of Education, Youth and Sports as LM2015064, Czech National Node to the European Infrastructure for Translational Medicine (01/01/2016 — 31/12/2019), supported by the European Regional Development Fund, within Operational Programme Research, Development and Education as CZ.02.1.01/0.0/0.0/16_013/0001818, Modernization and support of research activities of the national infrastructure for translational medicine EATRIS-CZ.